Literature DB >> 10900293

Vascular endothelial markers, von Willebrand factor and thrombomodulin index, are specifically elevated in type 2 diabetic patients with nephropathy: comparison of primary renal disease.

T Hirano1, K Ookubo, K Kashiwazaki, H Tajima, G Yoshino, M Adachi.   

Abstract

To elucidate the hypothesis that albuminuria in diabetic subjects reflects widespread vascular damage, plasma markers for vascular endothelial damage was measured in diabetic subjects with various degrees of albuminuria and compared to results in patients with primary renal disease. The groups consisted of 31 non-diabetic patient controls with normoalbuminuria, 109 type 2 diabetic patients with normo- micro- and macro-albuminuria, and 16 proteinuric patients with primary renal disease. Endothelial markers, plasma von Willebrand factor (vWF) and thrombomodulin (TM), were measured by enzyme-linked immunosolvent assay and enzyme immunoassay (EIA) methods, respectively. Plasma vWF levels were similar in controls (119+/-7%, mean+/-S.E.M.) and diabetic patients with normoalbuminuria (139+/-6), but significantly elevated in diabetic patients with microalbuminuria (174+/-11) and macroalbuminuria (204+/-17), while the level was not increased in patients with primary renal disease (124+/-11). Because plasma TM level was strongly affected by kidney function, TM index (TM (FU/ml)/serum creatinine (mg %)) was used as an endothelial marker. The TM index was substantially increased in diabetic patients with overt nephropathy compared with controls (5.29+/-2.98 vs. 2.35+/-0.85), whereas this was not observed in patients with primary renal disease (3.25+/-0.29). Both vWF and TM index were significantly higher in diabetic patients with retinopathy than in the patients without retinopathy. These results suggest that generalized vascular endothelial damage occurs in diabetic nephropathy including the microalbuminuric stage, which is not attributed to kidney damage per se.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10900293     DOI: 10.1016/s0009-8981(00)00274-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

1.  Cytokines profile and its correlation with endothelial damage and oxidative stress in patients with type 1 diabetes mellitus and nephropathy.

Authors:  Rodrigo M C Pestana; Caroline P Domingueti; Rita C F Duarte; Rodrigo B Fóscolo; Janice S Reis; Ana Maria S Rodrigues; Laís B Martins; Lirlândia P Sousa; Daniela P Lage; Cláudia N Ferreira; Adaliene V M Ferreira; Ana P Fernandes; Karina B Gomes
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

2.  ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.

Authors:  Nirav Dhanesha; Prakash Doddapattar; Mehul R Chorawala; Manasa K Nayak; Koichi Kokame; Janice M Staber; Steven R Lentz; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-11       Impact factor: 8.311

3.  The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Amit P Amin; Adam T Whaley-Connell; Suying Li; Shu-Cheng Chen; Peter A McCullough; Mikhail N Kosiborod
Journal:  Am J Kidney Dis       Date:  2013-04       Impact factor: 8.860

4.  Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation.

Authors:  Mehmet Polatli; Aysel Cakir; Orhan Cildag; A Zahit Bolaman; Cigdem Yenisey; Yavuz Yenicerioglu
Journal:  J Thromb Thrombolysis       Date:  2007-07-10       Impact factor: 2.300

Review 5.  Abnormal lipoprotein metabolism in diabetic nephropathy.

Authors:  Tsutomu Hirano
Journal:  Clin Exp Nephrol       Date:  2013-10-17       Impact factor: 2.801

6.  Endothelial dysfunction in geriatric diabetic patients: the role of microalbuminuria in elderly type 2 diabetic patients? A randomized controlled study.

Authors:  Mohamed A Helaly; Hussein A Sheashaa; El Sayed Z Hatata; Ansaf B Youssef; Asmaa Hegazi; Ibrahim A Abdel-Aal
Journal:  Int Urol Nephrol       Date:  2006-09-20       Impact factor: 2.266

7.  Activation of endothelial NAD(P)H oxidase accelerates early glomerular injury in diabetic mice.

Authors:  Hajime Nagasu; Minoru Satoh; Emi Kiyokage; Kengo Kidokoro; Kazunori Toida; Keith M Channon; Yashpal S Kanwar; Tamaki Sasaki; Naoki Kashihara
Journal:  Lab Invest       Date:  2015-11-09       Impact factor: 5.662

8.  ADAMTS13 predicts renal and cardiovascular events in type 2 diabetic patients and response to therapy.

Authors:  Erica Rurali; Marina Noris; Antonietta Chianca; Roberta Donadelli; Federica Banterla; Miriam Galbusera; Giulia Gherardi; Sara Gastoldi; Aneliya Parvanova; Ilian Iliev; Antonio Bossi; Carolina Haefliger; Roberto Trevisan; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  Diabetes       Date:  2013-06-03       Impact factor: 9.461

Review 9.  Pathophysiology of Diabetic Dyslipidemia.

Authors:  Tsutomu Hirano
Journal:  J Atheroscler Thromb       Date:  2018-07-12       Impact factor: 4.928

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.